MULTISITE PHASE II STUDY OF THE EFFICACY OF PEPTIDE T

肽 T 功效的多位点 II 期研究

• 批准号: 2320830
• 负责人: KARL GOODRIN
• 金额: $ 53.81万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 1992
• 资助国家: 美国
• 起止时间: 1992-09-08 至 1995-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2320830
• 关键词: MULTISITE; PHASE; II; STUDY; EFFICACY

The purpose of this project is to evaluate the clinical efficacy and safety of intranasally administered peptide T on cognitive impairment in HIV seropositive patients as assessed by neuropsychological measures. Other associated but secondary clinical measures will include the effect of peptide T treatment on motor or sensory neurologic function, as determined by physical examination. In addition, limited information will be sought regarding the effects of peptide T on laboratory measures of HIV caused immunologic dysfunction as well as human viral activity.

该项目的目的是评估临床功效和 鼻内施用肽T对认知障碍的安全性 通过神经心理学措施评估的HIV血清阳性患者。 其他相关但次要的临床指标将包括效果 在运动或感觉神经系统功能上的肽t处理 通过体格检查确定。 此外，信息有限 将寻求有关肽T对实验室措施的影响 HIV引起免疫功能障碍以及人类病毒活性。